<http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2657> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1752> . <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2657> <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P366> "NY-ESO-1_Peptide_Vaccine"^^<http://www.w3.org/2001/XMLSchema#string> . <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2657> <http://www.w3.org/2000/01/rdf-schema#label> "NY-ESO-1 Peptide Vaccine"^^<http://www.w3.org/2001/XMLSchema#string> . <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2657> <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P329> "38494"^^<http://www.w3.org/2001/XMLSchema#string> . <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2657> <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P97> "<n0:ComplexDefinition xmlns:n0=\"http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#\"><n0:def-definition>A cancer vaccine consisting of an immunogenic peptide derived from the cancer-testis antigen (NY-ESO-1), an antigen found in normal testis and various tumors. Vaccination with NY-ESO-1 peptide vaccine may stimulate the host immune system to mount a humoral and cytotoxic T lymphocyte (CTL) response to cells expressing NY-ESO-1 antigen, resulting in tumor cell lysis.</n0:def-definition><n0:def-source>NCI</n0:def-source></n0:ComplexDefinition>" . <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2657> <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P90> "<n0:ComplexTerm xmlns:n0=\"http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#\"><n0:term-name>ESO-1 Peptide Vaccine</n0:term-name><n0:term-group>SY</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm>" . <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2657> <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P330> "38494"^^<http://www.w3.org/2001/XMLSchema#string> . <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2657> <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P90> "<n0:ComplexTerm xmlns:n0=\"http://ncicb.nci.nih.gov/xml/owl/EVS/ComplexProperties.xsd#\"><n0:term-name>NY-ESO-1 Peptide Vaccine</n0:term-name><n0:term-group>PT</n0:term-group><n0:term-source>NCI</n0:term-source></n0:ComplexTerm>" . <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2657> <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P106> "Pharmacologic Substance"^^<http://www.w3.org/2001/XMLSchema#string> . <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2657> <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P108> "NY-ESO-1 Peptide Vaccine"^^<http://www.w3.org/2001/XMLSchema#string> . <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2657> <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#code> "C2657"^^<http://www.w3.org/2001/XMLSchema#string> . <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2657> <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P303> "Stage II; III; or IV Soft Tissue Sarcoma Expressing NY-ESO-1 or LAGE Antigen and High-Risk or Metastatic Melanoma."^^<http://www.w3.org/2001/XMLSchema#string> . <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2657> <http://www.w3.org/2000/01/rdf-schema#subClassOf> <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2517> . <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2657> <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P207> "C1134528"^^<http://www.w3.org/2001/XMLSchema#string> . <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2657> <http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2002/07/owl#Class> . <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C2657> <http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#P106> "Immunologic Factor"^^<http://www.w3.org/2001/XMLSchema#string> .